74 related articles for article (PubMed ID: 8546535)
1. Effects of the 5-hydroxytryptamine1A receptor agonists, 8-OH-DPAT, buspirone and flesinoxan, upon brain damage induced by transient global cerebral ischaemia in gerbils.
Piera MJ; Beaughard M; Michelin MT; Massingham R
Arch Int Pharmacodyn Ther; 1995; 329(3):347-59. PubMed ID: 8546535
[TBL] [Abstract][Full Text] [Related]
2. Lack of efficacy of 5-HT2A receptor antagonists to reduce brain damage after 3 minutes of transient global cerebral ischaemia in gerbils.
Piera MJ; Beaughard M; Michelin MT; Winslow E; Massingham R
Fundam Clin Pharmacol; 1995; 9(6):562-8. PubMed ID: 8808177
[TBL] [Abstract][Full Text] [Related]
3. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
[TBL] [Abstract][Full Text] [Related]
4. Effects of 5-HT1A receptor agonists on patterns of rat motor activity in relation to effects on forebrain monoamine synthesis.
Ahlenius S; Hillegaart V; Salmi P; Wijkström A
Pharmacol Toxicol; 1993 Jun; 72(6):398-406. PubMed ID: 8361951
[TBL] [Abstract][Full Text] [Related]
5. Effects of 5-hydroxytryptamine1A-receptor agonists on hippocampal damage after transient forebrain ischemia in the Mongolian gerbil.
Bode-Greuel KM; Klisch J; Horváth E; Glaser T; Traber J
Stroke; 1990 Dec; 21(12 Suppl):IV164-6. PubMed ID: 2148036
[TBL] [Abstract][Full Text] [Related]
6. 5-HT1A receptor agonists buspirone and gepirone attenuate apomorphine-induced aggressive behaviour in adult male Wistar rats.
Pruus K; Skrebuhhova-Malmros T; Rudissaar R; Matto V; Allikmets L
J Physiol Pharmacol; 2000 Dec; 51(4 Pt 2):833-46. PubMed ID: 11220492
[TBL] [Abstract][Full Text] [Related]
7. 5-HT1A receptor activation increases hippocampal acetylcholine efflux and motor activity in the guinea pig: agonist efficacy influences functional activity in vivo.
Wilkinson LO; Middlemiss DN; Hutson PH
J Pharmacol Exp Ther; 1994 Aug; 270(2):656-64. PubMed ID: 8071858
[TBL] [Abstract][Full Text] [Related]
8. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT2A/2C antagonist anxiolytics. I. Antipunishment effects in the pigeon.
Kleven MS; Koek W
J Pharmacol Exp Ther; 1996 Feb; 276(2):388-97. PubMed ID: 8632301
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of serotonin 5-HT 1A receptor activation against ischemic cell damage in gerbil hippocampus: Involvement of NMDA receptor NR1 subunit and BDNF.
Salazar-Colocho P; Del Río J; Frechilla D
Brain Res; 2008 Mar; 1199():159-66. PubMed ID: 18269931
[TBL] [Abstract][Full Text] [Related]
11. A new antioxidant drug limits brain damage induced by transient cerebral ischaemia.
Calapai G; Squadrito F; Rizzo A; Crisafulli C; Campo GM; Marciano MC; Mazzaglia G; Scuri R
Drugs Exp Clin Res; 1993; 19(4):159-64. PubMed ID: 8131711
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
13. Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications.
Ba M; Kong M; Ma G; Yang H; Lu G; Chen S; Liu Z
Brain Res; 2007 Jan; 1127(1):177-84. PubMed ID: 17113046
[TBL] [Abstract][Full Text] [Related]
14. Regionally selective effects of NMDA receptor antagonists against ischemic brain damage in the gerbil.
Warner MA; Neill KH; Nadler JV; Crain BJ
J Cereb Blood Flow Metab; 1991 Jul; 11(4):600-10. PubMed ID: 1828809
[TBL] [Abstract][Full Text] [Related]
15. The 5HT1A receptor agonist, 8-OH-DPAT, protects neurons and reduces astroglial reaction after ischemic damage caused by cortical devascularization.
Ramos AJ; Rubio MD; Defagot C; Hischberg L; Villar MJ; Brusco A
Brain Res; 2004 Dec; 1030(2):201-20. PubMed ID: 15571670
[TBL] [Abstract][Full Text] [Related]
16. 5-hydroxytryptamine1A agonists. A new therapeutic principle for stroke treatment.
Bielenberg GW; Burkhardt M
Stroke; 1990 Dec; 21(12 Suppl):IV161-3. PubMed ID: 2148035
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of the AMPA antagonist PNQX in oxygen-glucose deprivation in mouse hippocampal slice cultures and global cerebral ischemia in gerbils.
Montero M; Nielsen M; Rønn LC; Møller A; Noraberg J; Zimmer J
Brain Res; 2007 Oct; 1177():124-35. PubMed ID: 17894933
[TBL] [Abstract][Full Text] [Related]
18. Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.
Egashira N; Matsuda T; Koushi E; Mishima K; Iwasaki K; Shoyama Y; Fujiwara M
Eur J Pharmacol; 2006 Nov; 550(1-3):117-22. PubMed ID: 17022969
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like effects of 5-hydroxytryptamine1A receptor agonists on operant responding under a response duration differentiation schedule.
Kinney GG; Griffith JC; Hudzik TJ
Behav Pharmacol; 1998 Jul; 9(4):309-18. PubMed ID: 10065919
[TBL] [Abstract][Full Text] [Related]
20. Role of hippocampal serotonergic neurons in ischemic neuronal death.
Nakata N; Suda H; Izumi J; Tanaka Y; Ikeda Y; Kato H; Itoyama Y; Kogure K
Behav Brain Res; 1997 Feb; 83(1-2):217-20. PubMed ID: 9062688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
